Atinary is honored to announce that Professor Stephen L. Buchwald, the Camille Dreyfus Professor of Chemistry at the Massachusetts Institute of Technology (MIT), has joined Atinary’s Scientific Advisory Board. His groundbreaking work, including the renowned Buchwald–Hartwig reaction and Buchwald Ligands, revolutionized organic synthesis, medicinal chemistry, and catalyst design, and earned him the place as one of the most cited chemists in the world.

Professor Buchwald is a member of the American Academy of Arts and Sciences and the U.S. National Academy of Sciences. He has received numerous prestigious awards, including the Linus Pauling Medal, a MERIT award from the U.S. National Institutes of Health, the Wolf Prize in Chemistry, and the BBVA Foundation Frontiers of Knowledge Award. 

Dr. Hermann Tribukait, Co-Founder and CEO, shared:
“Steve’s exceptional contributions and deep expertise in chemistry will help us accelerate R&D and our mission to augment scientists to help them discover molecules exponentially faster with machine learning and robotics.”

Dr. Loïc Roch, Co-Founder and CTO, added:
“Professor Buchwald’s contributions are foundational to modern chemistry. As a chemist, I am honored and excited to work with him to advance Atinary’s AI-driven technology that can help address some of society’s biggest challenges.”

Reflecting on his appointment, Professor Buchwald said:
“I look forward to collaborating with Atinary at this transformative time in scientific discovery. Their technology has the potential to make a significant impact across diverse areas of chemistry and industries, from medicine to materials.”

Welcome, Professor Buchwald! With your expertise and our innovative team, we are accelerating the future of chemical innovation and discovery.

Explore the Buchwald Lab at MIT: https://chemistry-buchwald.mit.edu/
Learn more about Atinary’s mission and impact at https://atinary.com/